News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,476 Results
Type
Article (86760)
Company Profile (704)
Press Release (764010)
Multimedia
Podcasts (140)
Webinars (18)
Section
Business (232778)
Career Advice (4130)
Deals (39749)
Drug Delivery (129)
Drug Development (91070)
Employer Resources (198)
FDA (18164)
Job Trends (17356)
News (396730)
Policy (39803)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (103)
Alliances (56951)
ALS (113)
Alzheimer's disease (1541)
Antibody-drug conjugate (ADC) (186)
Approvals (18113)
Artificial intelligence (378)
Autoimmune disease (35)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (125)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (38)
Breast cancer (377)
Cancer (2952)
Cardiovascular disease (236)
Career advice (3537)
Career pathing (34)
CAR-T (201)
CDC (38)
Cell therapy (553)
Cervical cancer (24)
Clinical research (74086)
Collaboration (1057)
Company closure (3)
Compensation (658)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (320)
Cystic fibrosis (117)
Data (2920)
Decentralized trials (2)
Denatured (49)
Depression (67)
Diabetes (365)
Diagnostics (6965)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (167)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (126)
Earnings (97426)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131315)
Executive appointments (895)
FDA (19795)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (968)
Gene editing (142)
Generative AI (37)
Gene therapy (420)
GLP-1 (915)
Government (5237)
Grass and pollen (6)
Guidances (180)
Healthcare (20914)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (172)
Immuno-oncology (8)
Indications (38)
Infectious disease (3074)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (65)
Intellectual property (119)
Interviews (813)
IPO (17892)
IRA (55)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (54)
Layoffs (582)
Leadership (25)
Legal (10130)
Liver cancer (84)
Lung cancer (419)
Lymphoma (205)
Machine learning (9)
Management (65)
Manufacturing (415)
MASH (92)
Medical device (14699)
Medtech (14704)
Mergers & acquisitions (22541)
Metabolic disorders (926)
Multiple sclerosis (102)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2259)
NextGen: Class of 2025 (7687)
Non-profit (5088)
Now hiring (48)
Obesity (477)
Opinion (287)
Ovarian cancer (98)
Pain (115)
Pancreatic cancer (115)
Parkinson's disease (192)
Partnered (25)
Patents (301)
Patient recruitment (147)
Peanut (54)
People (65622)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22873)
Phase II (32164)
Phase III (24228)
Pipeline (1613)
Policy (229)
Postmarket research (3552)
Preclinical (10331)
Press Release (72)
Prostate cancer (142)
Psychedelics (40)
Radiopharmaceuticals (277)
Rare diseases (500)
Real estate (7399)
Recruiting (75)
Regulatory (27038)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (165)
Series B (108)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (63)
The Weekly (89)
Vaccines (884)
Venture capital (54)
Weight loss (325)
Women's health (48)
Worklife (20)
Date
Today (150)
Last 7 days (545)
Last 30 days (2518)
Last 365 days (34237)
2025 (17015)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (68)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50448)
Australia (8871)
California (7542)
Canada (2317)
China (693)
Colorado (324)
Connecticut (341)
Delaware (196)
Europe (115746)
Florida (1111)
Georgia (258)
Hawaii (1)
Idaho (65)
Illinois (720)
India (32)
Indiana (381)
Iowa (18)
Japan (221)
Kansas (115)
Kentucky (32)
Louisiana (17)
Maine (73)
Maryland (1078)
Massachusetts (5769)
Michigan (271)
Minnesota (470)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (73)
New Jersey (2107)
New Mexico (31)
New York (2118)
North Carolina (1219)
North Dakota (10)
Northern California (3248)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1618)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (35)
South Dakota (1)
Southern California (2774)
Tennessee (123)
Texas (1138)
United States (28509)
Utah (224)
Virginia (202)
Washington D.C. (80)
Washington State (666)
West Virginia (4)
Wisconsin (83)
There are 851,476 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
Washington’s Policy Shifts Are Driving Capital Away From Life-Saving Research
Drug pricing, budget cuts, tariffs and other shifts under the Trump administration undermine the biopharma and healthcare ecosystem.
June 24, 2025
·
4 min read
·
John Stanford
Rare diseases
FDA Conditional Pathway Not Necessary, Rare Disease Experts Say, While Applauding Intent
Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway proposed by FDA Commissioner Marty Makary. They acknowledged, however, that creative thinking is required to enable more treatments for patients with ultrarare diseases.
June 24, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025
June 23, 2025
·
3 min read
Press Releases
DeepEcho Reaches New Milestone With FDA 510(k) Clearance for AI-Powered Prenatal Imaging
June 23, 2025
·
2 min read
Press Releases
CCS Presents Four Peer-Reviewed Posters at American Diabetes Association’s 85th Scientific Sessions
June 23, 2025
·
4 min read
Press Releases
Niagen Bioscience to Participate at the Roth 15th Annual London Conference
June 23, 2025
·
2 min read
Press Releases
Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
June 23, 2025
·
9 min read
Press Releases
RESULTS FROM AMGEN’S PHASE 2 OBESITY STUDY OF MONTHLY MARITIDE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS
June 23, 2025
·
20 min read
Press Releases
New Formulations of GLP-1s Demonstrate Positive Results, Potentially Offering Additional Options for Obesity Medications
June 23, 2025
·
7 min read
Press Releases
Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions
June 23, 2025
·
8 min read
1 of 85,148
Next
